HealthSpring’s Part D lineup is built around one useful choice: basic coverage or a richer design
HealthSpring’s standalone Medicare Part D portfolio is easiest to understand as a choice between two different coverage strategies rather than two versions of the same plan. Assurance Rx is positioned as the more basic option, with emphasis on popular drugs, lower cost sharing at preferred pharmacies and a value-oriented design. Extra Rx is the richer option, with a larger formulary, broader pharmacy access and additional features for people who want more flexibility from their prescription coverage.
That distinction is why MarketReview rates the HealthSpring portfolio 4.5 out of 5 and identifies it as best for basic versus enhanced choice. The portfolio gives shoppers a clearer internal decision than a lineup where several plan names differ only slightly. You can start by asking whether you mainly want a leaner Part D plan for routine prescriptions or whether you are willing to pay for a design that may handle a wider range of medications and pharmacy situations more comfortably.
The tradeoff is that neither label settles the enrollment decision. Assurance can be the better value for one medication list and the worse value for another. Extra can justify its richer positioning for someone with several brand drugs while adding little for a person who mainly fills inexpensive generics. HealthSpring also uses preferred and standard pharmacy arrangements, so the same plan can look very different depending on where the prescriptions are filled.
The best use of the portfolio is therefore to treat Assurance and Extra as two starting points for the same drug-by-drug calculation. The lineup makes the first decision clearer. Your prescriptions and pharmacy make the final one.
Assurance Rx is the more straightforward value option
HealthSpring describes Assurance Rx as a Part D plan providing basic coverage on popular drugs. The company also highlights access to more than 26,000 preferred pharmacies and lower cost sharing at those preferred locations. That positioning makes Assurance the natural first plan to investigate when your medication list is relatively simple and you are willing to use pharmacies that receive the plan’s preferred pricing.
The word basic should not be interpreted as inadequate. A leaner plan can be exactly what a beneficiary needs when the important prescriptions are covered favorably and the monthly cost is competitive. The real question is whether the plan is basic in areas you do not care about or basic in an area that matters to you. A person taking a few common generics may find little value in paying for a richer design. Someone using several brand-name drugs can reach the opposite conclusion very quickly.
Preferred-pharmacy access is especially important to Assurance because it is part of the plan’s value proposition. HealthSpring’s pharmacy materials explain that preferred in-network pharmacies often offer lower copays than standard in-network pharmacies. That means Assurance should not be judged from its premium alone. If your regular pharmacy is standard rather than preferred, the plan may deliver less of the savings that make the design attractive.
Assurance is therefore strongest for a shopper who wants a simpler Part D structure, has a medication list that fits the formulary well and can make practical use of the preferred network. It is weaker when the savings depend on changing pharmacies or when one important prescription sits on an unfavorable tier or restriction.
Extra Rx earns its place by giving shoppers more room around the drug list
HealthSpring positions Extra Rx as the more flexible option, with a larger formulary and pharmacy network than the basic plan. The company also highlights features such as supplemental coverage for some non-Part D medications, low or $0 copays on certain drugs and a $0 deductible for many generic medications. Those features give Extra a different role in the portfolio rather than making it simply a more expensive version of Assurance.
The larger formulary is most relevant to people whose medication lists are less predictable or include more brand-name drugs. A plan that covers more drugs can reduce the chance that one prescription forces an exception request or pushes the beneficiary toward another carrier. It can also be useful for someone whose doctor may change a prescription during the year and who wants a wider set of formulary options inside the same plan.
Supplemental coverage for non-Part D medications deserves careful reading because it is easy to overvalue a benefit simply because it sounds broader. The useful question is whether the specific drugs you might use fall under that supplemental coverage and what the cost-sharing rules are. Extra should not be chosen merely because it contains more features. It should be chosen when those features reduce the expected cost or friction of your actual medication routine.
The richer design also creates a clearer comparison within the HealthSpring lineup. If Assurance covers all of your prescriptions well and the preferred-pharmacy pricing works, Extra may be unnecessary. If Assurance produces an unfavorable formulary result or a higher annual estimate, Extra gives you a second HealthSpring option before you have to leave the portfolio entirely.
HealthSpring’s pharmacy strategy is one of the strongest parts of the portfolio
HealthSpring makes pharmacy choice unusually central to its Part D materials. The company distinguishes between standard network pharmacies and preferred pharmacies, and it explains that preferred locations can offer lower out-of-pocket costs. That transparency is useful because pharmacy status is one of the easiest ways for a shopper to misunderstand Part D pricing.
The network includes large national chains, regional chains, grocery pharmacies and independent pharmacies. HealthSpring’s published preferred-network list includes names such as Walgreens, Walmart, Sam’s Club, Publix, Safeway, Wegmans, H-E-B and many regional operators. The important point is not the presence of any one chain. It is that the portfolio gives many shoppers a realistic chance of finding a preferred pharmacy without relying on one narrow retail channel.
Assurance and Extra also have plan-specific pharmacy directories, which matters because the exact network and preferred status can differ. A pharmacy appearing somewhere in HealthSpring’s broader Medicare network should not be treated as proof that it has preferred pricing under the exact Part D plan you are considering.
The correct comparison is simple: price the same prescription list at your current pharmacy and at one or two convenient preferred pharmacies. If the difference is small, convenience may win. If the difference is substantial, switching pharmacies can materially improve the value of the plan. HealthSpring’s portfolio rewards shoppers who are willing to make that comparison rather than treating pharmacy choice as an afterthought.
Express Scripts home delivery is a practical option for maintenance medications
HealthSpring uses Express Scripts Pharmacy as a preferred home-delivery option and Accredo for specialty pharmacy services. For people taking stable maintenance medications, this can reduce pharmacy trips and make longer fills easier to manage. HealthSpring says preferred home delivery can provide $0 or reduced copays on many generic medications, along with free shipping and refill-management tools.
The mail-order setup is more useful than a generic statement that home delivery exists. HealthSpring describes tracking notifications, refill reminders and automatic-refill options, and the pharmacy team is available around the clock. Those features can matter for someone managing several recurring medications or helping a family member keep prescriptions on schedule.
Mail order should still be compared with preferred retail. A person who has a convenient preferred pharmacy nearby may find that retail pricing is just as competitive and more flexible when a prescription changes. Someone who travels frequently or has difficulty reaching a pharmacy may value delivery much more.
Specialty drugs are another case where the channel matters. HealthSpring directs specialty home delivery through Accredo. That can create a more coordinated process for certain high-cost medications, but specialty-drug coverage still depends on the formulary, tier and utilization rules. A specialty pharmacy relationship does not by itself make an expensive drug affordable.
The formulary check matters more for HealthSpring than the plan-family label
HealthSpring provides separate drug-list resources and plan documents for Assurance Rx and Extra Rx. That is important because the two plan families can differ in how broadly they cover medications and how those medications are placed on tiers. A shopper who sees Extra described as the larger-formulary plan should still search every prescription rather than assuming the richer plan handles all drugs more favorably.
HealthSpring’s materials also make clear that quantity limits and other restrictions can apply. As with other Part D plans, prior authorization, step therapy and quantity limits can change the practical value of a covered drug. A prescription can appear on the formulary and still require additional work before the plan pays under the expected terms.
This matters especially for people taking several brand-name or specialty medications. A lower premium and low generic copays can look attractive while one expensive medication drives most of the annual cost. The better HealthSpring plan is the one that handles the medications that matter most, not the one with the most appealing generic-drug headline.
HealthSpring’s drug-search and plan-document tools give shoppers a reasonable path to verify those details before enrollment. Use them for the complete prescription list, including dose and frequency. If a drug has been difficult to cover in the past, look specifically for authorization or step-therapy requirements rather than stopping once the drug name appears in the formulary.
Annual formulary changes and medication management are worth checking before renewal
A Part D plan that works well today can become less attractive after a formulary, tier or pharmacy change. HealthSpring publishes Annual Notice of Change documents and updated formulary materials so members can see what is changing before the next coverage period. That is especially important for people taking a medication that sits on a higher tier or already requires an authorization.
Existing members should not rely on automatic renewal as proof that the plan remains a good fit. Compare the new formulary entry for every recurring prescription, check whether the pharmacy you use still has the same network status and look for changes in deductible treatment or cost sharing. A plan-family name can stay the same while the economics underneath it change.
HealthSpring also provides Medication Therapy Management resources for eligible members who use multiple medications. MTM is not a reason to choose the carrier by itself, but it can be useful for people managing complicated medication routines because it creates another structured opportunity to review drug use, potential interactions and adherence issues.
The value of these resources is practical rather than promotional. Annual notices help prevent surprises at renewal, while medication-management support can help members understand a complex drug regimen after enrollment. Neither replaces the initial formulary comparison, but both matter more for someone who expects to stay in the plan for more than one coverage period.
The premium difference only makes sense after you price the prescriptions
HealthSpring publishes state-specific premiums for Assurance Rx and Extra Rx, which reinforces an important Part D rule: the consumer-facing plan family is not one national price. Premiums can differ by state and region, and exact cost sharing can differ as well. That makes national statements such as “Assurance is cheaper” or “Extra costs more” too crude to guide an enrollment decision.
Assurance may have the lower premium in a particular location, but Extra can still produce the lower total annual cost if it places an important medication on a better tier or uses a more favorable deductible structure for the drugs you take. The opposite can happen when someone mostly uses inexpensive generics and the richer plan adds premium without adding meaningful savings.
This is one of the areas where HealthSpring’s two-plan design works well. The portfolio creates a natural like-for-like test. Price the exact same medication list under Assurance and Extra in the same location and at the same pharmacies. That lets you see what the richer design is actually buying rather than comparing marketing descriptions.
When the annual estimates are close, pharmacy convenience, mail-order preferences and formulary flexibility can break the tie. When one plan is clearly cheaper for the medications you use, the more expensive option needs a specific benefit that justifies the difference. Paying more simply because a plan is labeled enhanced is not a good Part D strategy.
The current CMS quality signal is the main weakness in HealthSpring’s case
HealthSpring’s standalone Part D contract S5617 carries a 2.5-star Part D summary rating in the CMS data supporting this review. That is a weaker quality signal than the portfolio’s consumer-facing plan design would suggest. It does not mean Assurance or Extra is automatically a poor financial fit, but it is a meaningful drawback when comparing two plans that otherwise produce similar prescription costs.
The useful way to interpret that result is as a secondary decision factor. Drug coverage, pharmacy access and annual cost should still come first because those directly determine whether the plan works for your prescriptions. If HealthSpring is materially better on those factors, the lower CMS quality rating should be weighed alongside that advantage rather than treated as an automatic rejection.
If HealthSpring and another carrier are close on cost and formulary fit, the quality signal becomes more important. A shopper should also check the current CMS Star Rating at the time of enrollment because the measure is updated periodically and belongs to the CMS contract rather than to the HealthSpring brand in the abstract.
This is the biggest reason the MarketReview Rating stops at 4.5 out of 5. The Assurance-versus-Extra structure is useful, the pharmacy strategy is strong and the home-delivery infrastructure is practical. The CMS quality signal prevents the portfolio from ranking with the strongest Part D options when the financial fit is otherwise comparable.
HealthSpring’s reworked brand is less important than the plan documents behind it
People who have seen older Cigna Healthcare Medicare drug-plan materials may encounter familiar plan names or documents while researching HealthSpring. The practical issue is not the branding history. It is whether the current Evidence of Coverage, formulary, pharmacy directory and member resources correspond to the plan being considered now.
HealthSpring maintains current Part D Evidence of Coverage documents for Assurance Rx and Extra Rx, along with plan-specific pharmacy directories, formulary resources and annual notices. Those are the materials that should drive the comparison. An older carrier name appearing in a prior-year document does not tell you what the current plan covers.
This is particularly important during annual enrollment, when beneficiaries may receive notices explaining a plan-name change, a consolidation or a transition from an older product. Read the current plan documents rather than assuming the old and new versions are identical. A familiar plan family can still change premiums, drug coverage or pharmacy arrangements from one plan year to the next.
For MarketReview’s purposes, HealthSpring is the consumer-facing Part D portfolio being reviewed. The exact CMS contract, plan family and regional plan remain the more precise layers for validating current terms.
The best HealthSpring choice is the one that makes the basic-versus-enhanced tradeoff obvious
HealthSpring deserves a place on the Part D shortlist when you want a clear internal choice between a leaner value design and a more flexible enhanced option. Assurance Rx gives cost-conscious shoppers a focused starting point, particularly when preferred-pharmacy access and common medications line up well. Extra Rx gives shoppers a second path when the medication list is more complicated or when broader formulary and supplemental features have real value.
The portfolio is less compelling when neither plan handles an important prescription well or when the pharmacies you want to use do not receive competitive cost sharing. In that situation, the fact that HealthSpring offers two distinct designs does not solve the core problem. Another carrier may simply fit better.
The cleanest decision process is to price Assurance and Extra side by side using the exact same prescriptions and pharmacies. Check the premium, deductible treatment, drug tiers, restrictions, preferred-pharmacy status and refill pattern. Then compare the cheaper HealthSpring result with the strongest plans from other carriers.
If Assurance wins, you have avoided paying for flexibility you do not need. If Extra wins, the richer design is earning its place in the portfolio. That is the strongest feature of HealthSpring’s Part D lineup: the two plans are different enough that the comparison can reveal something useful instead of merely giving shoppers another pair of names to sort through.